Back
Annovis Bio Vs. Perspective Therapeutics Industry Stock Comparison
Sell
12
ANVS
Annovis Bio
Last Price:
8.64
Seasonality Move:
-18.77%
Sell
31
CATX
Perspective Therapeutics
Last Price:
13.26
Seasonality Move:
-10.19%
Sell
12
Annovis Bio (ANVS)
is a Sell
Is Annovis Bio a Buy, Sell or Hold?
- The current Annovis Bio [ANVS] share price is $8.47. The Score for ANVS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- ANVS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
31
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $13.23. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANVS Stock Price Chart
What is Annovis Bio's stock price today?
-
The Annovis Bio share price today is $8.47
The current trend is relatively stagnant and ANVS is experiencing selling pressure, which indicates risk of future bearish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $13.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
ANVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.14 | Sell |
Relative Strength Index (14 RSI): | 48.53 | Sell |
Chaikin Money Flow: | -179716 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.13 - 9.15) | Sell |
Bollinger Bands (100): | (6.06 - 10.38) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 41.35 | Sell |
Chaikin Money Flow: | -3362413 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.88 - 15.76) | Sell |
Bollinger Bands (100): | (11.5 - 15.9) | Sell |
ANVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.41 | Buy |
20-day SMA: | 8.55 | Sell |
50-day SMA: | 9.25 | Sell |
200-day SMA: | 9.76 | Sell |
8-day EMA: | 8.43 | Buy |
20-day EMA: | 8.51 | Sell |
50-day EMA: | 8.73 | Sell |
200-day EMA: | 9.46 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.14 | Sell |
20-day SMA: | 14.89 | Sell |
50-day SMA: | 13.76 | Sell |
200-day SMA: | 11.32 | Buy |
8-day EMA: | 13.91 | Sell |
20-day EMA: | 14.32 | Sell |
50-day EMA: | 13.92 | Sell |
200-day EMA: | 11.52 | Buy |
Annovis Bio Earnings Growth & ANVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.
Annovis Bio Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |